本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Denali Therapeutics Inc.

15.50
+0.07000.45%
盘后15.500.00000.00%16:19 EDT
成交量:217.58万
成交额:3,348.15万
市值:22.66亿
市盈率:-5.52
高:15.69
开:15.45
低:15.06
收:15.43
52周最高:33.33
52周最低:10.57
股本:1.46亿
流通股本:1.32亿
量比:0.70
换手率:1.65%
股息:- -
股息率:- -
每股收益(TTM):-2.8082
每股收益(LYR):-2.5705
净资产收益率:-39.69%
总资产收益率:-24.99%
市净率:2.21
市盈率(LYR):-6.03

数据加载中...

2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/01

重要事件披露

Form 8-K - Current report
2024/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

重要事件披露

Form 8-K - Current report
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report